Invivoscribe’s EHA Symposiums Now Available on Demand

Last updated: 03rd February, 2022

Products are for professional/laboratory use only.

The Invivoscribe symposiums presented during the 25th European Hematology Association Virtual Congress are now available to watch on demand.

NGS-Based Clinical Assessment of Hematologic Malignancies: B- and T-Cell Clonality, Somatic Hypermutation and MRD Detection

Incorporating NGS Methods for Routine Clonality Assessment and Disease Monitoring of Lymphoid Malignancies
Dr. Maria Arcila – Memorial Sloan Kettering Cancer Center, NY, United States

Clonality analysis with NGS is the new frontier in MRD detection
Prof. Sara Galimberti – University of Pisa, Department of Clinical and
Experimental Medicine, Italy

Next Generation Analysis in CLL and Other Malignancies
Prof. Dr. Markus Tiemann – Institute for Hematopathology Hamburg, Germany

View Invivoscribe's EHA Symposiums on Demand

Click here >

LymphoTrack Dx IVD Assay kits are designed for the identification of gene arrangements in haematologic samples utilising NGS technologies.

Invivoscribe NGS assays offer:

  • Significant improvement over conventional fragment analysis of B- and T-cell gene rearrangements to provide detailed information regarding the DNA sequences, sequence frequency and mutational status (IGHV Leader and IGH FR1 assays only) of each clonotype
  • A complete solution with each kit containing ready-to-use indexed amplification master mixes, necessary controls and complimentary bioinformatics software
  • Streamlined workflow: primers are designed with barcoded indices and adaptors, sequencing libraries can be generated with one-step PCR, eliminating the need for a post-PCR ligation step
  • Assays for Illumina® MiSeq® and Thermo Fisher Scientific® platforms
  • Available as IVD, ARTG 255352

Find out more about Invivoscribe MRD T-Cell Bundled Solution

Click here >

Find out more about Invivoscribe MRD Controls

Click here >

Contact us for a quote

Contact Us Now >

Request a Quote

Request Quote

Go BackGo Back